Article information
Full text is only aviable in PDF
Bibliografía
[1.]
R.W. Viggiano, S.J. Swensen, E.C. Rosenow.
Evaluation and management of solitary and multiple pulmonary nodules.
Clin Chest Med, 13 (1992), pp. 83-95
[2.]
J.L. Westcott, N. Rao, D.P. Colly.
Transthoracic needle biopsy of small pulmonary nodules.
Radiology, 202 (1997), pp. 97-103
[3.]
Agencia de Evaluación de Tecnologías Sanitarias (AETS).
Instituto de Salud Carlos III-Ministerio de Sanidad y Consumo..
Tomografía por emisión de positrones (PET) con 18FDG en Oncología Clínica (revisión sistemática),
[4.]
J.L. Carreras.
Tomografía por emisión de positrones (PET) en el nódulo solitario pulmonar.
An R Acad Nac Med, 118 (2001), pp. 405-419
[5.]
J.A. Richter, W. Torre, C. Gámez, J.M. Aramendia, A. Crespo, A. Nicolas, et al.
Valor de la tomografía por emisión de positrones (PET)-18FDG en el cáncer de pulmón.
Med Clin (Barc), 113 (1999), pp. 567-571
[6.]
H.W. Prauer, W.A. Weber, W. Romer, T. Treumann, S.I. Ziegler, M. Schwaiger.
Controlled prospective study of positron emission tomography using the glucose analogue [18f] fluorodeoxyglucose in the evaluation of pulmonary nodules.
Br J Surg, 85 (1998), pp. 1506-1511
[7.]
V.J. Lowe, J.W. Fletcher, L. Gobar, M. Lawson, P. Kirchner, P. Valk, et al.
Prospective investigation of positron emission tomography in lung nodules.
J Clin Oncol, 16 (1998), pp. 1075-1084
[8.]
R.C. Hagberg, G.M. Segall, P. Stark, T.A. Burdon, M.F. Pompili.
Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography.
Eur J Cardiothorac Surg, 12 (1997), pp. 92-97
[9.]
N.A. Dewan, C.J. Shehan, S.D. Reeb, L.S. Gobar, W.J. Scott, K. Ryschon.
Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-pET scan.
Chest, 112 (1997), pp. 416-422
[10.]
M.K. Gould, C.C. McLean, W.G. Kuschner, C.E. Rydzak, D.K. Owens.
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions. A meta-analysis.
Jama, 285 (2001), pp. 914-924
[11.]
N.C. Gupta, J. Mallof, E. Gunel.
Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
J Nucl Med, 37 (1996), pp. 943-948
[12.]
S.S. Gambhir, M.E. Hoh, M.E. Phelps, I. Madar, J. Madahi.
Decision tree sensitivity analysis for cost-effectiveness of FDG-pET in the staging and management of non-small-cell lung carcinoma.
J Nucl Med, 37 (1996), pp. 1428-1436
[13.]
M.K. Gould, G.A. Lillington.
Strategy and cost in investigating solitary pulmonary nodules.
Thorax, 53 (1998), pp. S32-S37
[14.]
J.W. Fletcher, V.J. Lowe.
Is PET ready for prime time?.
J Nucl Med, 37 (1996), pp. 948-949
[15.]
S. Kosuda, K. Ichihara, M. Watanabe, H. Kobayashi, S. Kusano.
Decision- tree sensitivity analysis for cost-effectiveness of chest 2- fluoro-2-D-18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small-cell lung carcinoma) in Japan.
Chest, 117 (2000), pp. 346-353
[16.]
S.P. ChangLai, S.C. Tsai, M.C. Chou, Y.J. Ho, C.H. Kao.
Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer.
Oncol Rep, 8 (2001), pp. 337-339
[17.]
C.A. Kutlu, U. Pastorino, M. Maisey, P. Goldstraw.
Selective use of PET scan in the preoperative staging of NSCLC.
Lung Cancer, 21 (1998), pp. 177-184
[18.]
M. Tatsumi, K. Yutani, T. Nishimura.
Evaluation of lung cancer by 99mTc-tetrofosmin SPECT: comparison with [18F] FDG-pET.
J Comput Assist Tomogr, 24 (2000), pp. 574-580
[19.]
G.M. Graeber, N.C. Gupta, G.F. Murray.
Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease.
J Thorac Cardiovasc Surg, 117 (1999), pp. 719-727
[20.]
E.M. Marom, H.P. McAdams, J.J. Erasmus, P.C. Goodman, D.K. Culhane, R.E. Coleman, et al.
Staging non-small cell lung cancer with whole-body PET.
Radiology, 212 (1999), pp. 803-809
[21.]
W. Weder, R.A. Schmid, H. Bruchhaus, S. Hillinger, G.K. Von Schulthess, H.C. Steinert.
Detection of extrathoracic metastases by positron emission tomography in lung cancer.
Ann Thorac Surg, 66 (1998), pp. 886-892
[22.]
H.C. Steinert, M. Hauser, F. Allemann, H. Engel, T. Berthold, G.K. Von Schulthess, et al.
Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
Radiology, 202 (1997), pp. 441-446
[23.]
J.F. Vansteenkiste, S.G. Stroobants, P.J. Dupont, P.R. De Leyn, W.F. De Wever, E.K. Verbeken, et al.
FDG-pET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group.
Eur J Nucl Med, 25 (1998), pp. 1495-1501
[24.]
J.F. Vansteenkiste, S.G. Stroobants, P.R. De Leyn, P.J. Dupont, E.K. Verbeken.
Potential use of FDG-pET scan after induction chemotherapy in surgically staged IIIa-n2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group.
Ann Oncol, 9 (1998), pp. 1193-1198
[25.]
T. Bury, A. Barreto, F. Daenen, N. Barthelemy, B. Ghaye, P. Rigo.
Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.
Eur J Nucl Med, 25 (1998), pp. 1244-1247
[26.]
K. Higashi, T. Nishikawa, H. Seki, M. Oguchi, Y. Nambu, Y. Ueda, et al.
Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
J Nucl Med, 39 (1998), pp. 9-15
[27.]
H.W. Prauer, W.A. Weber, W. Romer, T. Treumann, S.I. Ziegler, M. Schwaiger.
Controlled prospective study of positron emission tomography using the glucose analogue [18f] fluorodeoxyglucose in the evaluation of pulmonary nodules.
Br J Surg, 85 (1998), pp. 1506-1511
[28.]
K. Higashi, Y. Ueda, Y. Arisaka, T. Sakuma, Y. Nambu, M. Oguchi, et al.
18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
J Nucl Med, 43 (2002), pp. 39-45
[29.]
M. MacManus, K. Wong, R.J. Hicks, J.P. Matthews, A. Wirth, D.L. Bali.
Early mortality after radical radiotheraphy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center.
Int J Radiat Oncol Biol Phys, 52 (2002), pp. 351-361
[30.]
K. Mah, C.B. Caldwell, Y.C. Ung, C.E. Danjoux, J.M. Balogh, S.N. Ganguli, et al.
The impact of 18FDG-pET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study.
Int J Radiat Oncol Biol Phys, 52 (2002), pp. 339-350
Copyright © 2002. Sociedad Española de Neumología y Cirugía Torácica
